Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06256432
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-02-05
Brief Title:
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Sponsor:
Noorik Biopharmaceuticals AG
Organization:
Noorik Biopharmaceuticals AG
Organization Data
Organization:
Noorik Biopharmaceuticals AG
Class:
INDUSTRY
Study ID:
N-003-CRD005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Noorik Biopharmaceuticals AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None